HNW Monthly Performance – September 2025

In September, the HNW Australian Equity Portfolio had experienced a challenging month, declining -2.65% and underperforming the benchmark return of -0.78%, primarily due to macroeconomic factors rather than the outlook for company profits in 2026. Investors were probably due for a weaker [...]

2025-11-13T09:48:20+11:00October 3, 2025|

HNW Monthly Performance – August 2025

In August, the HNW Australian Equity Portfolio had a had a challenging month, finishing up +1.34% and behind the ASX 200 TR (ex LPT) return of 3.01%. A disappointing outcome over a month that saw significant volatility, with the average results day trading range of close [...]

2025-09-18T16:20:03+10:00September 4, 2025|

Reporting Season – Wesfarmers

Wesfarmers (WES) presented its full-year 2025 results, which were better than expected, demonstrating that WES's businesses are performing well and taking market share. WES shares were priced for perfection heading into the results, and that is largely what they delivered, something [...]

2025-11-13T10:42:39+11:00August 28, 2025|

Reporting Season – Medibank Private Ltd

Medibank Private (MPL): This morning, Australia's largest health insurer reported its full-year 2025 results, which showed that MPL's disciplined approach to volume growth has won over the long term. The HNW Portfolio holds a 3% in MPL. Key Points: Record Profits: Medibank recorded [...]

2025-11-13T10:41:18+11:00August 28, 2025|

Reporting Season – Sonic Healthcare Ltd

Sonic Healthcare (SHL). This morning, global pathology company SHL reported its full-year profit results, which were solid but a little below expectations. The HNW Portfolio has a 3.5% weight to Sonic. Key Points: Profits: Profits increased by +7% to $514 million but [...]

2025-11-13T10:36:10+11:00August 21, 2025|
Go to Top